In addition, Chen et al. demonstrated that both the ratio of Bax/Bcl-2 and the cleavage of PARP significantly increased in ISL-treated antibody-containing cells (ACC) cells [33]. This evidence concerns the gene BAX and adrenal cortex carcinoma.